NCT00134732 Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis Status COMPLETED Phase PHASE3
NCT00134719 Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines Status COMPLETED Phase PHASE2
NCT00134693 A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT00133874 Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo Status COMPLETED Phase PHASE3
NCT00133848 Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment Status COMPLETED Phase PHASE3
NCT00131820 Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam Status COMPLETED Phase PHASE4
NCT00131664 Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study) Status COMPLETED Phase PHASE3
NCT00129363 Study to Evaluate the Safety of Twice Daily Oral Carvedilol Status COMPLETED Phase PHASE3
NCT00129129 Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine Status COMPLETED Phase PHASE2
NCT00129116 3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age Status COMPLETED Phase PHASE2
NCT00128661 Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants Status COMPLETED Phase PHASE3
NCT00127855 Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine Status COMPLETED Phase PHASE2
NCT00127608 Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients Status COMPLETED Phase PHASE3
NCT00127023 Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Status COMPLETED Phase PHASE3
NCT00127010 Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Status COMPLETED Phase PHASE3
NCT00126997 Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Status COMPLETED Phase PHASE4
NCT00126984 Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine Status COMPLETED Phase PHASE2
NCT00126945 Evaluate 4 Different Formulations of Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs Status COMPLETED Phase PHASE2